Recent Finacing
Recent Raise
Gedea Biotech develops pHyph, an antibiotic-free vaginal tablet with GDA 001 that restores vaginal pH, disrupts BV biofilm, and is in clinical development for EU and US approvals.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Gedea Biotech.
